Melanoma-Targeted Chemothermotherapy and <i>In Situ</i> Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles

<table>Conjugates of NPrCAP/magnetite nanoparticles for developing melanogenesis-targeted melanoma nanomedicine.</table>

Journal of Skin Cancer

fig4

Figure 4

Figure 4: Melanoma-Targeted Chemothermotherapy and <i>In Situ</i> Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles 

Figure 4 | Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles 